Vanderbilt University Licenses Ariadne Pathway Studio
News Jul 12, 2007
Ariadne has announced that Vanderbilt University purchased an unlimited Pathway Studio license for the Department of Cancer Biology. Pathway Studio was chosen for its flexibility in exploring protein-protein interactions and ease of frequent database updates with MedScan® module.
“We evaluated various pathway analysis packages and were impressed by Pathway Studio’s graphics and ease of use.” said Dr. Lynn Matrisian, Chair of the Department of Cancer Biology at Vanderbilt University.
“Most impressive is the MedScan Technology that allows our researchers to extract relationships from the latest publications and add them to the large body of knowledge in the packaged database. The ability to instantly update the database with selected information is of paramount importance in cancer research," Dr. Matrisian continued.
‘We start seeing more and more research groups choosing Pathway Studio over other pathway software based on the availability of MedScan and therefore the researcher’s ability to fully control the database and update it as often as needed”, said Ilya Mazo, President of Ariadne.
“Ease of making custom databases together with the biggest available database of functional relationships and flexibility of pathway analysis queries proves to be the most important advantages of our software among researchers in academia and pharmaceutical companies.”
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.